The University of Texas MD Anderson Cancer Center (colloquially MD Anderson Cancer Center) is a comprehensive cancer center in Houston, Texas
The Latest Bing News on:
University of Texas MD Anderson Cancer Center Research
- MD Anderson and Advanced Biology collaborate to host the virtual Cancer Neuroscience Symposium
The University of Texas MD Anderson Cancer Center will host the virtual Cancer Neuroscience Symposium Sept. 22-23, 2022, in collaboration with the journal Advanced Biology.
- Science Reveals That This Type of Diet Can Increase Your Risk of Pancreatic Cancer
According to a new study, substances that are said to boost athletic performance can also activate a receptor that speeds up the development of pancreatic cancer in mice. The progression of precancero ...
- New Leukemia-Killing Compounds Discovered
New study highlights potential of mitochondria-targeted chemotherapies. Scientists have discovered promising new drugs that work in concert with other drugs to deliver a deadly one-two punch to ...
- MD Anderson appoints division head of pathology and laboratory medicine
Donna Hansel, MD, PhD, has been named division head of pathology and laboratory medicine at The University of Texas MD Anderson Cancer Center.Hansel’s appointment will take effect Sept. 12.
- MD Anderson named #1 in the nation for cancer care
The institution has been one of the nation’s top two hospitals for cancer care since the survey’s inception in 1990 ...
The Latest Google Headlines on:
University of Texas MD Anderson Cancer Center Research
The Latest Bing News on:
University of Texas MD Anderson Cancer Center Discovery
- MD Anderson again ranked best cancer hospital in US
The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country.MD Anderson tops U.S. News & World Report’s 2022-2023 Best Hospitals rankings ...
- New Leukemia-Killing Compounds Discovered
New study highlights potential of mitochondria-targeted chemotherapies. Scientists have discovered promising new drugs that work in concert with other drugs to deliver a deadly one-two punch to ...
- MD Anderson appoints division head of pathology and laboratory medicine
Donna Hansel, MD, PhD, has been named division head of pathology and laboratory medicine at The University of Texas MD Anderson Cancer Center.Hansel’s appointment will take effect Sept. 12.
- Biopharma has a brand new target: Cancer-specific collagen
Researchers at the University of Texas MD Anderson Cancer Center published a new study revealing that cancer cells make their own unique form of collagen to help them grown and proliferate. This means ...
- MD Anderson, Obsidian get US FDA clearance to begin phase I study of novel TIL therapy, OBX-115 to treat solid tumours
MD Anderson, Obsidian get US FDA clearance to begin phase I study of novel TIL therapy, OBX-115 to treat solid tumours: Houston, Texas Friday, July 22, 2022, 18:00 Hrs [IST] The U ...